Protein in Urine: What a Urinalysis Finding Means for Your Kidneys

The video is fifteen seconds long. A hand tilts a phone toward a toilet bowl, the water holds a stubborn cap of white foam, and the caption reads: “This is what kidney failure looks like.” Millions of views later, clinics are fielding a new kind of question from people who feel perfectly well and simply noticed some bubbles. As of early 2026, searches for protein in urine have climbed alongside two quieter shifts: mail-order urine test strips paired with smartphone apps, and updated kidney guidance from the CDC and NIH that treats urine albumin as a routine annual check for anyone with diabetes or high blood pressure.

The result is a collision of anxiety and genuinely good medicine. A urinalysis, the standard dipstick-and-microscope check of a urine sample, has been part of physicals for a century. What has changed is how seriously a small amount of protein is now taken, and how much can be done about it.

Foam, it turns out, is a poor witness. The numbers are far better ones.

Why protein in urine is suddenly on everyone's lab report

Three currents are meeting at once. The first is technological: inexpensive urine strips that once lived only in clinic drawers are now sold in ten-packs with an app that photographs the color change. People who never had a reason to test their urine are testing it weekly, and strips are designed to be sensitive rather than specific. A faint “trace” reading is common and, in most healthy people, means very little.

The second current is social. Foamy urine has become shorthand online for kidney disease, and while heavy, persistent foam can accompany large protein losses, ordinary bubbles from a fast stream or a bit of cleaning product in the bowl look almost identical. The claim is not invented, but it has been stretched well past what the evidence supports.

The third current is the one that matters most. Kidney medicine has moved from watching kidney damage to actively slowing it. Large randomized trials over the past decade showed that certain blood pressure and diabetes medicines protect kidneys most clearly in people who have measurable albumin in their urine. That turned a once-passive finding into a treatment trigger. The CDC now estimates that roughly 35.5 million US adults, about 1 in 7, have chronic kidney disease, and that as many as 9 in 10 do not know it. The NIH’s kidney institute lists a urine albumin test alongside a blood test as the two-step screen for anyone at risk.

Put those together and the flood of questions makes sense. More people are being tested, more people are testing themselves, and the finding carries more consequence than it did a generation ago. Sorting the trivial from the meaningful is the whole task.

What does protein in urine actually mean?

Each kidney holds about a million glomeruli, microscopic tufts of blood vessels that act as filters. A glomerulus lets water, salts and waste pass into the urine while holding back blood cells and large proteins. The busiest protein in the blood is albumin, which keeps fluid inside vessels and ferries hormones and medicines around the body. Healthy filters keep almost all of it.

The kidneys process roughly 180 liters of blood plasma a day, and even at that volume a healthy adult loses less than 150 milligrams of protein in urine daily, an amount too small for a standard dipstick to register. When the filter’s fine mesh is inflamed, scarred or stretched by high pressure, albumin slips through. Doctors call this albuminuria; when other proteins leak too, the broader term is proteinuria.

There is a second route worth knowing. The tubules downstream of the glomerulus normally reabsorb the small proteins that do get filtered. Damage to the tubules, or a flood of small proteins from elsewhere in the body, can also raise urine protein even when the filters are intact. This is why a clinician sometimes orders tests beyond the dipstick.

Why the fuss over a little lost albumin? Because it does double duty as a signal. Albumin in the urine reflects damaged kidney filters, but it also mirrors the health of the lining of blood vessels everywhere. Observational studies following hundreds of thousands of people have found that higher urine albumin predicts heart attack, stroke and death independently of blood pressure or cholesterol. A urine sample, in other words, is a window onto the vascular system, not only the kidneys.

How a urinalysis detects protein in urine

Most people first learn about protein in urine from a dipstick. A plastic strip with chemical pads is dipped in the sample; the protein pad shifts from yellow toward green in proportion to how much albumin is present, and the result is read as negative, trace, or 1+ through 4+. It is fast, cheap and reasonably good at catching moderate to large amounts of albumin.

It has real limits. Concentrated urine after a hot day can push a normal person into the trace range, while dilute urine after several glasses of water can hide a genuine leak. Very alkaline urine, some antiseptics and recent strenuous exercise can produce false positives. The pad is also tuned to albumin and largely misses other proteins, including the immunoglobulin fragments seen in some blood disorders.

Because of this, the dipstick is a screen, not a verdict. The test that clinicians rely on is the urine albumin-to-creatinine ratio, or uACR. Creatinine is a muscle waste product excreted at a fairly steady rate, so dividing albumin by creatinine cancels out how concentrated the sample is. A uACR below 30 milligrams per gram is normal; 30 to 300 is moderately increased; above 300 is severely increased. Because albumin varies day to day, guidance from the NIH kidney institute asks for at least two of three samples over about three months to be abnormal before labeling the finding persistent.

Two other tests round out the picture. A protein-to-creatinine ratio captures all proteins, not just albumin. A 24-hour urine collection, once the gold standard, is now reserved for specific situations because the spot ratios track it closely. A blood test for creatinine gives the estimated glomerular filtration rate, or eGFR, a measure of how much blood the kidneys clean per minute. Urine albumin and eGFR together define kidney health far better than either alone.

What changed recently

The most consequential shift is in how kidney disease is staged and treated, and it happened in steps rather than with a single announcement.

For decades, kidney disease was graded almost entirely by eGFR. Current NIH and CDC guidance now describe a two-dimensional picture: the eGFR stage on one axis and the urine albumin category on the other. Two people with the same eGFR but different uACR results can face very different risks, and the person with more albumin generally faces the higher one. The NIH’s National Institute of Diabetes and Digestive and Kidney Diseases explicitly recommends that people with diabetes, high blood pressure, heart disease or a family history of kidney failure have both tests, and the CDC’s kidney testing guidance echoes this with a yearly interval for people with diabetes or hypertension.

The second change is therapeutic. Between roughly 2019 and 2023, several large randomized trials of SGLT2 inhibitors, a class of medicines originally developed for type 2 diabetes that make the kidneys excrete more glucose, reported that they slowed loss of kidney function and reduced progression to kidney failure by roughly a third in people with chronic kidney disease, with or without diabetes. Trial entry criteria leaned heavily on measurable albuminuria. A newer class of mineralocorticoid receptor antagonists showed kidney and heart benefits in people with diabetes and albuminuria. These results are why clinicians are asking for urine samples they might once have skipped.

The third change is cultural and less tidy: consumer strips and viral videos have moved the finding from the clinic into the bathroom. Mayo Clinic and Cleveland Clinic patient pages now spend as much space explaining what a single trace reading does not mean as what it might. That balance is the honest one, and it shapes everything that follows.

Is protein in urine very serious?

The truthful answer is that it depends entirely on three things: how much, how long, and what else is going on.

Start with how long. Transient proteinuria appears after a fever, a hard workout, emotional stress, a urinary tract infection or a day of poor hydration, and vanishes on retesting. It is common, especially in young adults, and carries no known long-term consequence. Orthostatic proteinuria, in which protein appears only when someone has been upright and disappears in the first morning sample collected after lying down all night, affects a meaningful share of teenagers and young adults and is considered benign. A clinician can check for it with a simple first-void sample.

Persistent proteinuria is different. Protein that shows up on repeat samples spaced weeks apart suggests the filter is damaged rather than merely stressed. Here the amount steers the seriousness. A uACR between 30 and 300 milligrams per gram indicates early kidney damage and elevated cardiovascular risk but is often silent and, with treatment of the underlying cause, may stabilize or fall. Values above 300 point to more advanced disease. At the far end, losses above roughly 3.5 grams of protein per day define nephrotic-range proteinuria, a level at which the blood runs low on albumin, fluid seeps into tissues and swelling becomes visible.

Then there is context. A trace reading in an otherwise healthy 25-year-old after a marathon is a footnote. The same reading in someone with fifteen years of diabetes is a prompt for a proper uACR. Pregnancy changes the calculus entirely: new protein in urine after 20 weeks, particularly with raised blood pressure, is evaluated urgently for preeclampsia, a pregnancy complication that can escalate quickly.

Serious, then, is a spectrum. Most single findings sit at the harmless end. The job of follow-up is to find out where yours sits.

What causes protein buildup in urine when the kidneys are fine?

The phrase “protein buildup” is a slight misnomer; protein does not accumulate in urine so much as leak into it. Understanding the everyday triggers explains why one result so often fails to repeat.

Vigorous exercise is the classic example. Running, weightlifting and long cycling sessions raise blood flow through the kidneys and briefly change how the filters handle albumin. Protein can appear for up to a day or two afterward and then clear. Fever does something similar through inflammation and altered kidney blood flow, which is why a urinalysis done during a bad cold is not the one to worry about.

Dehydration concentrates everything in the urine, including the small amount of protein everyone excretes, nudging a dipstick from negative to trace without any real increase in loss. Urinary tract infections shed white blood cells and bacteria into the urine, both of which can raise protein readings; treating the infection and retesting usually settles the question. Cold exposure, intense emotional stress and, in some people, a very large protein-rich meal can all produce short-lived rises.

Standing itself is a cause in orthostatic proteinuria, discussed above, which is why clinicians sometimes ask for a first-morning sample.

Certain medicines can raise urine protein as a side effect, including some anti-inflammatory painkillers and specific antibiotics and cancer drugs. This is not a reason to stop anything; it is a reason to make sure the prescribing clinician knows the result, because they can weigh the medicine’s benefit against the finding and decide whether monitoring or a change is warranted. That decision belongs to them, never to a test strip.

The pattern across all these causes is the same. Remove the trigger, retest under ordinary conditions, and the protein is gone. When it is not, the search moves to the kidneys themselves.

Kidney and whole-body conditions that cause persistent proteinuria

Two conditions account for most persistent protein in urine in the United States, and neither is rare.

Diabetes is the leading cause. Years of elevated blood glucose damage the glomerular filters and thicken their walls, allowing albumin through. This diabetic kidney disease often begins as a uACR in the 30 to 300 range while eGFR is still normal, which is precisely why the American Diabetes Association and NIH guidance call for annual urine albumin testing in everyone with diabetes. Caught at that stage, treatment can substantially slow the decline.

High blood pressure is the second. Sustained pressure inside the tiny glomerular capillaries scars them over time, and the resulting albumin leak both signals the damage and, some evidence suggests, contributes to further scarring. Controlling blood pressure lowers urine albumin in most people, a rare instance where treating the cause and watching the marker respond happens within weeks.

Beyond these two lie the glomerular diseases proper: inflammatory conditions such as IgA nephropathy, lupus nephritis and various forms of glomerulonephritis, in which the immune system attacks the filter. These often announce themselves with blood in the urine alongside protein and may require a kidney biopsy, a procedure in which a needle removes a tiny sample of tissue for microscopic examination, to name precisely.

Systemic conditions round out the list. Heart failure, obesity and sleep apnea are each associated with higher urine albumin. Multiple myeloma and related plasma cell disorders produce abnormal small proteins that overwhelm the tubules; standard dipsticks can miss them, which is one reason a clinician may order a broader protein test in an older adult with unexplained findings. Preeclampsia in pregnancy has its own section in every kidney text for good reason.

Knowing the cause is not academic. Almost every treatment decision that follows a persistent finding depends on it.

Reading your numbers: dipstick results versus uACR categories

Lab reports rarely explain themselves, and the two common ways of reporting protein in urine use different scales. The table below lines them up. It is an orientation, not a diagnosis; only a clinician who knows your history can interpret a result properly.

Dipstick reading	Approximate albumin concentration	uACR category (mg/g)	What it usually indicates
Negative	Below detection	Under 30 (A1, normal to mildly increased)	No measurable leak; routine follow-up per risk factors
Trace	Roughly 15 to 30 mg/dL	Often under 30 to low 30s	Frequently transient; confirm with uACR if risk factors present
1+	Roughly 30 mg/dL	Often 30 to 300 (A2, moderately increased)	Repeat testing warranted; common in early diabetic or hypertensive kidney disease
2+ to 3+	Roughly 100 to 300 mg/dL	Frequently above 300 (A3, severely increased)	Persistent results indicate significant kidney damage; specialist input often sought
4+	1,000 mg/dL or more	Well above 300; may approach nephrotic range	Requires prompt evaluation, especially with swelling

A few cautions make the table more useful. The dipstick columns describe concentration, so a dilute sample with a real leak can read low and a concentrated sample with a trivial one can read high; this is exactly the problem the uACR solves. The uACR categories come from international kidney guidance adopted in NIH and CDC materials and apply to adults. Children, pregnant people and adults with very high or very low muscle mass need adjusted interpretation because creatinine excretion differs.

If one number deserves a place in your memory, it is 30 milligrams per gram. Below it, the filters are holding. Above it, on repeated samples, is the point where the evidence for early treatment becomes strong.

What the evidence actually says about protein in urine and kidney outcomes

Evidence in medicine comes in tiers, and it helps to know which tier supports each claim about proteinuria.

The strongest evidence, from randomized controlled trials, supports three points. First, in people with diabetic kidney disease and albuminuria, medicines that block the renin-angiotensin system, the ACE inhibitors and angiotensin receptor blockers, reduce urine albumin and slow progression to kidney failure; landmark trials in the early 2000s established this and it has held up since. Second, SGLT2 inhibitors reduce the risk of kidney function decline, kidney failure and death from kidney or cardiovascular causes in adults with chronic kidney disease, with the largest absolute benefit in those with higher albuminuria. Third, lowering blood pressure to guideline targets reduces albuminuria and slows kidney damage in people with hypertension.

The middle tier, large observational cohorts, supports the prognostic claims. Pooled analyses of more than a million participants show that higher uACR predicts cardiovascular events and mortality in a graded fashion across every level of eGFR and in people without diagnosed kidney disease. Observation cannot prove that albumin itself causes harm, but it firmly establishes it as a marker worth tracking.

The weakest tier, expert opinion and small studies, covers many of the questions people ask most. Whether dietary protein restriction helps in early disease has mixed trial support and is generally reserved for more advanced stages under dietitian supervision. The exact retesting interval after a first abnormal result is a reasoned convention rather than a trial-proven number. Claims for specific supplements have no randomized evidence behind them.

One well-designed trial deserves its own mention because it answers a question everyone asks: a one-year randomized study of adults with moderate chronic kidney disease found that coaching people to drink an extra liter or more of water daily did not slow the decline in kidney function compared with usual intake. That result sits directly against a very popular belief, and the next section takes it up.

Can drinking water reduce protein in urine?

Drinking more water can lower the concentration of protein in a single urine sample. It cannot reduce the amount of protein the kidneys are leaking. Those are two different statements, and the gap between them is where a lot of confusion lives.

Consider how a dipstick works. It reports concentration: milligrams of albumin per deciliter of urine. Drink a liter of water and the same daily albumin loss is spread through a larger volume, so the pad shifts toward negative. Nothing about the kidney filter has changed. This is why a first abnormal dipstick is often followed by a uACR, which corrects for concentration by comparing albumin to creatinine and is largely unaffected by how much someone drank that morning.

The idea that hydration heals kidneys is intuitive, and it earned a proper test. Researchers randomized adults with moderate chronic kidney disease to either coaching that raised their water intake by about a liter or more a day or to their usual habits, then followed them for a year. Kidney function declined at essentially the same rate in both groups. Adequate hydration remains sensible, particularly for preventing kidney stones and avoiding the strain of true dehydration, but the trial gives no support to drinking extra water as a treatment for proteinuria.

There is a further wrinkle for people with more advanced kidney disease or heart failure: their clinicians may actually ask them to limit fluids because damaged kidneys cannot always excrete the excess. Following general internet advice to “flush the kidneys” could work against a carefully set plan.

So the practical guidance is modest and unglamorous. Drink enough that you are not thirsty and your urine is pale rather than dark. Give a urine sample under ordinary conditions rather than after deliberately loading up on water, because a diluted sample can mask a finding your clinician needs to see. Let the uACR, not the color of a strip, carry the weight.

How can I clear protein in my urine? What treatment actually targets

No treatment exists for proteinuria as such. What exists, and works, is treatment of the condition producing it, with the urine albumin serving as a readout of whether that treatment is succeeding.

For transient causes, the fix is simply time and a retest. Resolve the infection, recover from the illness, skip the marathon the day before the sample, and the protein clears on its own.

For persistent proteinuria tied to diabetes or high blood pressure, the approach rests on the randomized evidence described earlier. Blood pressure control is foundational, and clinicians commonly favor an ACE inhibitor or angiotensin receptor blocker because these medicines reduce pressure inside the glomerulus specifically and lower urine albumin beyond what their blood pressure effect alone would predict. For people with type 2 diabetes or chronic kidney disease, SGLT2 inhibitors have joined the standard approach on the strength of trials showing slowed kidney decline. Newer mineralocorticoid receptor antagonists have trial support in diabetic kidney disease with albuminuria. Whether any of these medicines suits an individual, and in what combination, is a decision for the prescribing clinician, who weighs kidney function, potassium levels, other medicines and personal circumstances.

Glucose control in diabetes matters in its own right. Sustained improvements in blood sugar reduce the risk of developing albuminuria and slow its progression once present.

Lifestyle measures have supporting rather than starring roles. Reducing dietary sodium enhances the effect of blood pressure medicines on urine albumin. Weight loss in people with obesity lowers albuminuria in observational and small trial data. Stopping smoking, which damages blood vessels including those in the kidney, is consistently associated with better kidney outcomes. Avoiding routine use of nonsteroidal anti-inflammatory painkillers is standard advice for anyone with reduced kidney function, though any change to a medicine should go through the person who prescribed or recommended it.

Immune-mediated glomerular diseases require their own specialist-directed therapies, often after biopsy. Here, too, falling urine protein is how success is measured.

Common myths about protein in urine, corrected

Foamy urine means kidney failure. Heavy, persistent foam that lingers like the head on a beer can accompany large protein losses, and it deserves a test. Ordinary bubbles from a forceful stream, a concentrated morning sample or residue of toilet cleaner look nearly identical and mean nothing. Foam is a prompt for a urinalysis, not a diagnosis.

Eating protein causes protein in urine. A high-protein meal can nudge a dipstick briefly in some people, but dietary protein does not cause persistent proteinuria in healthy kidneys. The reverse worry, that everyone with protein in urine must cut dietary protein, is also overstated; restriction is a specialist decision typically reserved for more advanced disease.

One positive test means kidney disease. Guidance from the NIH kidney institute requires abnormal results on at least two of three samples over about three months before calling albuminuria persistent, precisely because single readings so often reflect exercise, fever or dehydration.

Supplements can “detox” the kidneys and clear protein. No randomized trial supports any supplement for reducing proteinuria. Some, particularly high-dose products and certain herbal preparations, are associated with kidney injury. Anyone with kidney findings should tell their clinician about every supplement they take.

Protein in urine only affects older people. Orthostatic proteinuria is most common in teenagers and young adults. Glomerular diseases such as IgA nephropathy frequently appear in the twenties and thirties. Preeclampsia affects pregnant people of every age.

If you feel fine, your kidneys are fine. Early kidney disease is almost always silent. The CDC’s estimate that up to 9 in 10 adults with chronic kidney disease are unaware of it is the clearest rebuttal.

Home strips are as good as a lab test. Consumer strips are screening tools with meaningful false-positive and false-negative rates. A lab uACR corrects for concentration and is the result on which decisions are made.

Who should be screened for protein in urine, and how often

Routine urine protein screening of healthy adults with no risk factors is not currently recommended by major US guidance, in part because transient results in low-risk people generate more worry than benefit. Screening is targeted instead at people whose kidneys are already under threat, where finding albuminuria early changes management.

The CDC and the NIH kidney institute identify the groups who should have a urine albumin test, generally alongside a blood eGFR:

• Adults with diabetes of either type. For type 2 diabetes, testing begins at diagnosis; for type 1, it typically begins about five years after diagnosis. Testing is then repeated at least yearly.
• Adults with high blood pressure, tested at least once a year.
• People with heart disease or heart failure.
• People with a family history of kidney failure.
• People with obesity, and some guidance includes adults over 60 and those of racial and ethnic backgrounds with higher rates of kidney failure.

Pregnancy carries its own schedule: urine is checked for protein at prenatal visits because new proteinuria after 20 weeks is a defining feature of preeclampsia.

For people who already have persistent albuminuria, the interval tightens. Clinicians commonly recheck uACR and eGFR one to three times a year depending on how high the numbers are and how fast they are changing, and a clear rise in albumin often prompts a treatment review. Someone whose uACR falls after starting a kidney-protective medicine is seeing the evidence work in real time.

The message for anyone with a risk factor is direct. If it has been more than a year since you gave a urine sample, or if you have never had a uACR reported, it is a reasonable thing to raise at your next visit. It is a small test with an outsized capacity to change what happens next.

When to see a doctor about protein in urine

Any positive protein result on a urinalysis, including a home strip, is worth discussing with a clinician, who can decide whether to repeat it, order a uACR, or simply note it. That conversation can usually wait for a routine appointment. Some situations cannot.

Seek care promptly, within a day or so, if protein in urine appears alongside any of the following:

• New swelling of the ankles, legs, hands or around the eyes, particularly puffiness of the face on waking
• Urine that is visibly pink, red or cola-colored, or a lab report showing blood as well as protein
• Persistently and markedly foamy urine that does not settle
• A noticeable drop in how much urine you are passing
• Unexplained fatigue, loss of appetite, nausea or a metallic taste
• Fever with pain in the side or back, which can signal a kidney infection

Seek emergency care immediately if protein in urine occurs with shortness of breath, chest pain, confusion, or an inability to pass urine.

Pregnancy has its own red flags. After 20 weeks, protein in urine together with a severe headache, visual disturbances such as flashing lights or blurring, pain under the ribs on the right side, sudden swelling of the face or hands, or a blood pressure reading of 140/90 or higher warrants same-day contact with the maternity team. Preeclampsia can progress in hours.

People with known kidney disease should contact their clinician if a repeat uACR has risen substantially, if they develop new swelling, or if they are prescribed a new medicine by another provider, since dosing of many drugs depends on kidney function.

Every decision about testing, medicines and follow-up belongs to the clinician who knows your history. This article can help you ask better questions; it cannot answer them for your particular kidneys.

Frequently asked questions

Is protein in urine very serious?

A single positive result is usually not serious and often disappears on retesting. Protein that persists over several months, particularly with diabetes, high blood pressure, swelling or blood in the urine, signals kidney damage that needs evaluation. The amount matters: a uACR of 30 to 300 mg/g indicates early damage, while values above 300 or visible swelling point to more significant disease.

How can I clear protein in my urine?

Protein clears when its cause is treated. Transient causes such as fever, exercise or infection resolve on their own. Persistent protein from diabetes or hypertension typically falls with blood pressure and glucose control, and clinicians often prescribe medicines with trial evidence for lowering albumin and protecting kidneys. Which medicine, if any, is right for you is a decision for your prescribing clinician.

What causes protein buildup in urine?

Protein appears in urine when kidney filters leak albumin or when tubules cannot reabsorb small proteins. Short-term triggers include heavy exercise, fever, dehydration, urinary infections and standing for long periods. Persistent causes include diabetes, high blood pressure, glomerular diseases such as IgA nephropathy or lupus nephritis, heart failure, obesity, preeclampsia in pregnancy and, less commonly, plasma cell disorders.

Can drinking water reduce protein in urine?

Drinking water dilutes a urine sample and can turn a dipstick from trace to negative, but it does not reduce the amount of protein the kidneys are leaking. A randomized one-year trial in adults with moderate kidney disease found extra water intake did not slow kidney decline. Stay adequately hydrated, but rely on the uACR, which corrects for concentration, rather than dipstick color.

What does protein on a urinalysis mean if I feel completely well?

Early kidney damage is almost always silent, so feeling well does not rule it out. In someone without risk factors, a trace or 1+ dipstick reading is frequently transient and is usually repeated under ordinary conditions. In someone with diabetes, high blood pressure or a family history of kidney failure, the same result should prompt a urine albumin-to-creatinine ratio and a blood test of kidney function.

Does foamy urine always mean protein in urine?

No. Foam commonly results from a forceful stream, concentrated urine or cleaning residue in the toilet, none of which involve protein. Heavy foam that persists like a beer head over days can accompany large protein losses and deserves a urinalysis. Foam is a reasonable reason to request a test, not evidence of kidney disease on its own.

What is the difference between a dipstick and a uACR test?

A dipstick measures protein concentration in a single sample and is affected by how dilute or concentrated the urine is. The urine albumin-to-creatinine ratio divides albumin by creatinine, a steadily excreted muscle waste product, which cancels out concentration and gives a result comparable across samples. The dipstick screens; the uACR, repeated over time, is what clinicians use for diagnosis and monitoring.

Can high blood pressure cause protein in urine?

Yes. Sustained high pressure inside the tiny glomerular capillaries scars the kidney filters and allows albumin to leak, making hypertension the second most common cause of persistent proteinuria after diabetes. Bringing blood pressure to guideline targets reduces urine albumin in most people, often within weeks, and clinicians frequently choose medicines that lower pressure inside the glomerulus specifically.

Is protein in urine during pregnancy dangerous?

Small amounts early in pregnancy can be normal or reflect a urinary infection. New or rising protein after 20 weeks, especially with blood pressure of 140/90 or higher, headache, visual changes, right-sided upper abdominal pain or sudden swelling, is evaluated urgently for preeclampsia, which can progress quickly. Contact your maternity team the same day if these features appear together.

How often should protein in urine be rechecked?

After a first abnormal dipstick, clinicians generally repeat testing with a uACR, aiming for two of three samples over about three months to confirm or rule out persistent albuminuria. People with diabetes or high blood pressure should be tested at least yearly even with normal results. Those with confirmed albuminuria are typically rechecked one to three times a year depending on the level and trend.

References

• Protein in Urine (MedlinePlus Medical Test)
• Chronic Kidney Disease Tests & Diagnosis (NIH NIDDK)
• Kidney Testing (CDC)
• Proteinuria (Cleveland Clinic)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.